Companies similar to SEMENTIS
Sign up to Download

1-30 of 6,714,272 results

  • www.baxerna.eu
  • 1
  • 1
Current bacterial vaccine development is hampered by a lack of known antigens & limited ability to elicit cellular immune responses... MTB, which causes tuberculosis, is the world's leading infectious killer. The only available vaccine against MTB..
Relevance: 23.271236
  • sementis.com.au
  • 14
Sementis is developing a vaccine to protect against COVID-19, the biggest global health challenge of our generation. A combination vaccine to guard against Zika and chikungunya virus infection has been shown effective in advanced preclinical..
Relevance: 22.958687
  • www.mcmvaccine.com
  • 1
MCM Vaccine B.V. is a European joint venture formed between Sanofi Pasteur Inc. and Merck & Co., Inc., Rahway, NJ USA (known as MSD outside US and Canada). The partnership combines innovation and expertise to offer an hexavalent pediatric vaccine.....
Relevance: 22.53318
  • flugen.com
  • 1
  • 2
  • 16
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. The M2SR Vaccine Platform has the potential to revolutionize the $5 billion annual influenza market, with a clinically-tested vaccine..
Relevance: 22.460361
  • redrockbiologics.com
  • 1
Red Rock Biologics develops novel vaccine technologies and supplies the resulting products to veterinarians. Red Rock's sister company, Hygieia Biological Laboratories, has been an industry leader in the research, development and manufacturing of..
Relevance: 22.12694
  • onehealthventures.com
  • 1
  • 1
  • 1
One Health Ventures Limited (OHV) is a research and development company established to develop treatments against pathogens and diseases that affect animals and may cross over into humans. OHV's first project is to develop a vaccine against epsilon..
Relevance: 21.804873
  • www.euvaccine.eu
  • 1
  • 1
  • 28
The European Vaccine Initiative (EVI) is a leading European non-profit Product Development Partnership (PDP) that is supporting global efforts to develop effective and affordable vaccines against diseases of poverty and emerging infectious..
Relevance: 21.761902
  • imutex.com
  • 2
  • 2
  • 4
Imutex is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate development of both vaccines... Imutex is leveraging technology licensed from PepTcell to develop a Broad-Spectrum ‘Universal' Influenza..
Relevance: 21.093962
  • rbdcov.eu
  • 4
  • 3
  • 2
RBDCOV, a clinical trial towards a COVID-19 vaccine for children, adolescents and immunocompromised people using a recombinant protein... RBDCOV aims to generate robust data to demonstrate the safety and immunogenicity* of this vaccine given as a..
Relevance: 21.023472
  • www.biologicsresources.com
a Vaccine and BioPharma company developing new and comprehensive medical countermeasures to protect human life against bioterrorism...
Relevance: 20.87907
  • ntpharminternational.com
  • 1
  • 1
1-The ZYCOV-D Vaccine does not use any genetic components of the virus or any virus components. The vaccine uses a new DNA technology using E-coli to develop antibodies against the virus. This technology can be applied to develop dozens of other..
Relevance: 20.83405
  • www.ingelvacflex.co.uk
  • 1
  • 1
Proven protection against wasting disease with the world's most widely used PCV2 vaccine 1..
Relevance: 20.57402
  • www.vaccinedevelopment.org.uk
  • 1
These two process maps were developed by the UK Vaccine R&D Network, to show key stages in both human vaccine development and veterinary vaccine development up to Phase III clinical trials or veterinary field trials. The Network is supporting vaccine..
Relevance: 20.391575
  • www.valneva.us
Valneva USA Inc. is focused on the marketing and distribution of Valneva's vaccine IXIARO® against Japanese Encephalitis...
Relevance: 20.361607
  • www.hgco19.com
Scientific Title: Randomized, Phase I/II, Placebo-controlled, Dose-Ranging, Study to Evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy adult subjects... Public Title: Safety and..
Relevance: 20.21948
  • www.vaccineformulationinstitute.org
  • 2
  • 1
The Vaccine Formulation Institute is dedicated to improving Global Health by developing high-quality, innovative adjuvants to vaccine developers and manufacturers worldwide, to protect those most in need against infectious diseases... VFI is a..
Relevance: 19.949911
  • valneva.com
  • 9
  • 15
  • 21
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. Valneva has leveraged its expertise and capabilities both to commercialize three..
Relevance: 19.922607
  • testeja.org
Don't want to take the vaccine against COVID-19 or perform a mandatory PCR/AG test in order to access some event? We have a scientific solution!..
Relevance: 19.869022
  • www.chulavrc.org
  • 17
  • 2
  • 6
As summarized in the above figure, Chula VRC is able to conduct for almost complete R&D capacity chain of a mRNA vaccine candidate from the antigen design to mRNA production, LNP encapsulation, in vitro and in vivo preclinical testing. And Chula VRC..
Relevance: 19.86802
  • www.illinoisvaccinates.com
The goal of I-VAC (Illinois Vaccinates) is to ensure Illinoisans are being immunized against COVID-19 at every opportunity and providers are prepared to immunize all eligible age-groups... The goal of I-VAC is to ensure Illinoisans are being..
Relevance: 19.866
  • vaccineslab.wordpress.com
  • 1
Vaccineslab targeted to track lists COVID-19 vaccine candidates currently in Phase 1-3 trials, as well as major candidates in pre-clinical stages of development and research... Track Treat Tracing COVID-19 vaccines worldwide Researchers worldwide..
Relevance: 19.777077
  • integratedbiotherapeuticvaccines.com
  • 1
  • 10
Prior vaccines developed for S. aureus, which were composed of surface antigens, failed clinically. At IBV, we are taking a different, more promising approach, and have developed IBT-V02, the first entirely toxoid-based vaccine designed to protect..
Relevance: 19.620642
  • www.fluclinic2you.com
  • 1
At FluClinic2You, we provide the quadrivalent flu vaccine to our clients. This vaccine works against 4 different strains of the virus... At FluClinic2You our specialised team of pharmacists come to your company to provide on-site corporate flu..
Relevance: 19.619429
  • www.captivatepharma.com
  • 2
  • 1
CaPtivate Pharmaceuticals LLC was incorporated in 2011 as a spin-off from BioSante Pharmaceuticals (currently ANI Pharmaceuticals). It is a preclinical-stage biotechnology company based in greater Philadelphia - Pennsylvania Biotechnology Incubator,..
Relevance: 19.56698
  • sarscov2variants.com
  • 2
In the event of SARS-CoV-2 vaccine-resistant strain emergence, we would like to quickly determine which vaccines are affected. Differences in national vaccination coverage, vaccine efficacy, viral phylogenetics, and infection reporting means that a..
Relevance: 19.396442
  • bionet-asia.com
  • 1
  • 2
  • 11
BioNet is the world's only manufacturer of licensed recombinant pertussis vaccines containing a genetically-inactivated pertussis toxin (PTgen)... BioNet is now developing a pancoronavirus mRNA vaccine with the support from CEPI. BioNet is leading a..
Relevance: 19.368263
  • immunize.io
  • 1
  • 2
Established in 2018, Immunize.io is a Registered BC Non-profit organization dedicated to improving community and global immunization rates. Vaccinations are considered one of the greatest public health interventions saving countless lives from..
Relevance: 19.272596
  • www.sypharma.com.au
  • 1
  • 1
  • 8
Sypharma is an independent Australian owned company, based in Melbourne's eastern suburb of Dandenong, Victoria... Sypharma partners with Vaxine to manufacture Covid-19 product 01/07/2020 Around the world, pharmaceutical manufacturers and..
Relevance: 19.081507
  • dhvi.duke.edu
  • 7
  • 1
  • 41
The CHAVI-ID built upon this work and developed first generation HIV-1 immunogens to induce HIV-1 protective antibodies, and established a translational pipeline to dramatically accelerate HIV-1 vaccine development with our own GMP manufacturing..
Relevance: 19.037975
  • techimmune.com
  • 1
  • 2
  • 7
TechImmune is advancing the development of a next-generation, broad-spectrum COVID vaccine, designed to obviate the necessity for frequent updating and recurrent boosting that characterize existing vaccines. Our innovative strategy targets multiple..
Relevance: 18.95611